ArticleNature communications2026

Non-lytic viral immunotherapy induces long-term glioblastoma survival and tumor-specific immunity without eliciting an antiviral response.

Alexander F Haddad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.